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Abstract
Alzheimer’s disease (AD) is America’s most common neurodegenerative disease
affecting over 5.4 million Americans (Fernández et al., 2017). A literature review was completed
to assess the possible relation between physical activity and the progression of AD. Articles were
collected from various peer-reviewed, published journals using the available databases of
Western Michigan University library which included PubMed, ClinicalTrials.gov, and the
National Institute of Health (NIH). Keywords used for the database searches included
“Alzheimer”, “Alzheimer’s Disease”, “neurodegeneration”, “aging brain”, “exercise”, and
“physical activity”. Based upon the literature reviewed, aerobic exercise appears to slow the
progression of AD and possibly reverses it slightly in some cases. Neurologically this is
observed with -amyloid plaques and neurofibrillary tangles beginning to breakdown, and
hippocampal volume increasing. There are a few instances where neural synapses increase, and
neuronal activity improves. As the cause of AD is still predominantly unknown, there are very
few treatments and prevention opportunities available at this time, therefore, many people are
turning towards non-pharmacological care such as physical exercise.
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Introduction
Affecting over 5.4 million adults, Alzheimer’s Disease (AD) is the most common
neurodegenerative disease in America (Fernández et al., 2017). It is primarily characterized by
the buildup of -amyloid plaques and tau proteins creating neurofibrillary tangles in the frontaltemporal regions of the brain (Fernandez et al., 2017). AD is thought to be the result of genetic
inheritance, but an official cause has not been discovered. Different forms of the disease may
have different onset times (Ryman et al., 2014), but no matter how AD develops in someone’s
brain, very few treatments are available to slow the progression once it begins. Even within these
treatments, the effectiveness of each depends on the individual. Research is shifting its focus
towards preventative medicine, especially regarding AD. One research area that may prove to be
promising is the relationship between AD and physical activity.
Alzheimer’s can be diagnosed from a number of factors such as memory loss,
performance on verbal or written tests, and/or by diagnostic scans. A Mini-Mental State
Examination (MMSE) can test a patient’s mental competence, while an MRI or CT scan may
display physical brain abnormalities. AD can be described based on the age of onset being
“early” or “late”, and the stage of the disease as “mild”, “moderate” or “severe” (Ryman et al.,
2014).
In a healthy human brain, exercise can improve brain plasticity and may “arrest, slow
down or even reverse the pathophysiological evolution to Mild Cognitive Impairment (MCI)”
(Foster, 2015). Physical exercise appears to lessen the effects of age-related deterioration on
three important brain networks. Brain plasticity can be observed in healthy brains which are
often creating new synapses while degrading old connections. Often, excess elimination of
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synapses is what can lead to cognitive impairments such as AD or other neurodegenerative
diseases (Foster, 2015). Another indication of AD is decreased levels of brain-derived
neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) circulating in the
body which is related to smaller hippocampal volume and a decline in learning and memory.
Although levels of VEGF decrease with age, BDNF and VEGF amounts are altered with
exercise, and can then have lasting effects on the plasticity and neural connections in the brain
(Voss et al., 2013).
Within the brain, many biochemical abnormalities are observed with the progression of
AD. The most common identifying factors of the disease are the creation of -amyloid plaques in
the brain, neurodegeneration, and a decrease in hippocampal volume (Gomez-Pinilla & Hillman,
2013). The specifics of how Alzheimer’s is triggered is still a mystery, but there are some genes,
such as Apolipoprotein E (APOE), that are considered risk factor genes. Their presence in the
genome seems to increase the risk of developing AD (Soto et al., 2015). Often the gene still
needs to be triggered by some environmental factor or event for AD to begin.
Many studies have been completed to compare the effect of exercise on the progression
of AD. The studies have utilized different types of exercise including aerobic, strength, and
alternative exercises such as yoga and tai chi (Mooventhan & Nivethitha, 2017). These various
exercise categories have different levels of effectiveness in AD patients with aerobic exercise
presenting positive results most frequently. Exercise has been shown to affect hippocampal
volume, increased APOE stabilization, and increased brain mitochondrial fitness or efficiency as
well as increased BDNF, VEGF, and insulin-like growth factor type 1 (IGF-1) levels (Bernardo
et al., 2016; Foster, 2015).
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Animal studies have also been done to test the efficacy of exercise for slowing disease
progression. The question is, do animal studies produce valid data or are they a distraction?
There have been conflicting views, but overall, they have produced similar results to human
trials. With animal studies, there are more factors to consider than in humans because of the
innate differences in their genome, and how the experiment is completed. For example, in animal
studies, the Alzheimer’s gene is purposely introduced into the body and triggered. This could
lead to some discrepancies when comparing to human trials, however it is still more ethical to
begin with animal trials before testing on humans.
There are many factors to consider in relation to the treatment of neurodegenerative
diseases including the cause of the disease, the method of action behind the disease, and how the
body reacts to such treatments. Because much is still unknown about AD, pharmacological
treatments have been difficult to formulate. Therefore, the purpose of this literature review is to
present research related to the effectiveness of different types of exercise on slowing the
progression of Alzheimer’s Disease. Additionally, there will be a discussion on current clinical
trials, as well as, a proposed future study.
Methodology
Published and Peer-reviewed articles were collected from many sources, mainly the
Western Michigan University library databases. Online journal databases such as PubMed,
Medline, ClinicalTrials.gov, and National Institute of Health (NIH) were the primary sources for
much of the literature found. The specific search terms included “Alzheimer”, “Alzheimer’s
Disease”, “neurodegeneration”, “aging brain”, “exercise”, “physical activity” and varying
combinations of these key words. Therefore, we will review Alzheimer’s Disease, it’s definition,
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diagnosis, how it’s affected by exercise, exercise as a treatment, and current and future
treatments/ studies.
What is Alzheimer’s Disease?
AD is a type of dementia determined by neurofibrillary tangles and amyloid plaques
building up in the brain. This buildup leads to neurodegeneration and inevitably, loss of memory
and cognitive function. In the absence of disease, any frequently used or overlearned abilities are
considered “crystallized intelligence” and typically remain stable or may slightly improve with
normal aging. Types of memory that are in this category include vocabulary, and spatial
perception. On the other hand, the ability to problem solve and think reasonably under varying
circumstances fall under “fluid intelligence”. Chains of thought that fall under “fluid
intelligence” include executive functions, processing speed, attention, and declarative memory.
These “fluid intelligence” activities tend to decline with healthy aging, however, the
deterioration does not typically impact their ability to complete everyday tasks or activities
(Tyndall et al., 2018, p. 216). AD and other neurodegenerative diseases promote the decline in
memory and general cognitive ability even after everyday tasks become impossible.
In the absence of AD, many elderly individuals experience amyloid deposition in their
brain. According to research conducted by Aizenstein et al. (2008), about 50% of people over 65
years old have some level of amyloid deposition in their brain, but half of these people do not
show symptoms. It was shown that about 21% of the people studied who have amyloid deposits
are not cognitively impaired. Therefore, it cannot be deduced just because there are amyloid
plaques in the brain, that a patient will have a decrease in cognitive functioning (2008).
Cognitive decline is based on observed symptoms and previously the only way to detect amyloid
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plaques was during an autopsy, however, PET scans can now show images of the affected areas
of patients in vivo.
APOE is the most commonly studied genetic variant relating to late onset Alzheimer’s
disease (LOAD). The ԑ4 allele on APOE seems to increase the risk of developing LOAD the
most and is a frequent topic of study of the APOE gene. The chance of developing LOAD
increases two and a half times for carriers of the ԑ4 allele, while having two copies of the ԑ4
allele increases the risk 16 times (Tyndall et al., 2018). This demonstrates a strong relation
between the presence of the allele and the onset of AD. Early onset AD, on the other hand,
appears to relate more with genetic variants (Tyndall et al., 2018). Variants specifically in the
APP, PSEN1, and PSEN2 genes have been associated with mostly early onset AD, but also some
late onset familial and sporadic cases have shown some variation in APP, PSEN1, and PSEN2.
The aggregation of tau proteins, which are considered another hallmark of AD, are encoded by
the MAPT gene. Studies completed regarding this hypothesis have conflicting results but reveal
the relation of MAPT variants increasing risk for AD, particularly in people who are not carriers
of the APOE ԑ4 allele. In one study, researchers identified 36 different Mendelian variants in 11
genes, including APP, PSEN1, PSEN2, and MAPT, that can affect the chance of developing AD.
It was also observed that genetic variants similar to those may cause early onset AD and relate
with other neurodegenerative diseases including Parkinson’s disease (PD), Amyotrophic lateral
sclerosis (ALS), and Frontotemporal lobar degeneration (FTD) (Fernández et al., 2017).
However, there is still a lot that we don’t know about the cause or causes of AD, and there could
still be many factors that lead to its onset that are yet to be discovered.
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Physical exercise and the brain
Though there is no cure for AD, research has been conducted to find either preventative
methods or treatment options to slow the progression. One potential treatment may be increasing
physical activity. We know that healthy brains are positively affected by physical activity. After
every workout, the brain’s dopamine, serotonin, and noradrenaline levels are higher than normal.
This can improve mood, but also increase attention span, focus, and eventually memory (Suzuki,
2017).
Aerobic Exercise
Exercise has been shown to influence brain plasticity in a variety of ways. In one study,
healthy sedentary individuals between the ages of 55 and 80 years old were randomly divided
into either the aerobic (walking) group or the non-aerobic, flexibility, toning, and balance (FTB)
group. It was noted that the FTB group was possibly altering the results by testing the social
aspect of group exercise along with FTB exercises, while the walking group tested brain function
as a direct result of aerobic activity (Voss et al., 2013). In the walking group, it was
recommended that participants walk in their target heart rate zone each week with a five-minute
warm up and cool down surrounding the activity. In the FTB group, the four different exercises
were changed every three weeks, always including toning exercises, yoga sequences, balance
practice, and an exercise of their choice, along with warm up and cool down periods. The first
week they focused on learning the exercise, while during weeks three and four, they increased
the intensity by adding more weights or repetitions. There were positive relationships shown
between BDNF and IGF-1 serum levels, hippocampal volume, and aerobic exercise, however,
these were not significant in the FTB group (Voss et al., 2013). Because of the more social and
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team-like atmosphere of the FTB group, we cannot determine that any outcomes are from
exercise alone. The comparison eventually demonstrated the plasticity of the brain in healthy
adults, however, it is impossible to know if the increase in social interaction of the FTB group
had any significant effect on brain plasticity along with the type of exercise.
Aerobic exercise affects the function of the brain by influencing BDNF, IGF-1, and
VEGF levels. Increases in BDNF can also be associated with greater hippocampal volume
leading to an increase in cognitive ability (Voss et al., 2013). The details are still unclear about
how this works on a molecular level. Without dementia, adults already lose 1-2% of their
hippocampal volume per year. The most atrophied areas after the age of 30 are the prefrontal,
neostriatal, and hippocampal regions. Degradation of these sections first, causes memory to be
the first cognitive ability to wane (Tyndall et al., 2018). Because BDNF, IGF-1, and VEGF
function most apparently in the lateral and temporal lobes, they often play a major role in
minimizing cognitive decline as well (Voss et al., 2013). The temporal lobes are involved with
processing sensory input and associating senses and emotion with memories. These areas are the
main regions of interest when finding ways to combat AD, and because BDNF, IGF-1, and
VEGF appear to increase growth and survival of specific subtypes of neurons, this neurogenesis
could reduce the effects of AD (Bernardo et al., 2016).
Aerobic exercise is associated with increases in gray and white matter in both healthy
older adults as well as those with dementia. This increase is primarily in the temporal,
hippocampal and prefrontal regions. This further illustrates the plasticity of the brain in response
to exercise (Tyndall et al., 2018). Because the brain demonstrates plasticity or remodeling,
aerobic exercise may be a path to positively alter brain function. Braskie et al. (2014)
investigated 82 individuals at least 65 years old from the Cardiovascular Health Study (observing
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coronary heart disease and stroke in the older population) who had neurological and
neuropsychological exams that appeared “cognitively intact at baseline”. Of these individuals, 43
remained cognitively intact for the study while 39 developed AD before the final MRI was
completed. The researcher found that lower physical activity intensity strongly related both with
those who developed AD before the MRI and those who had lower brain volume after 9 years,
while controlling for other factors affecting brain atrophy including age, sex, diagnosis of AD,
and BMI (Braskie et al., 2014). In this study, they also noticed the year-nine reported physical
activity values were not significantly related to brain volume. However, this could be from
inaccurate reporting of physical activity from the AD patients. Another possibility for this
contradiction is that long term effects of exercise are more effective at increasing brain volume
than the immediate effects of exercise (Braskie et al., 2014).
Alternative Exercise
Other types of exercise focusing on mindfulness, tai chi, and the practice of yoga have
also been observed with regards to neurological disorders. Combining mind therapy with
physical motion can produce some interesting results with neurotransmitters and hormones in the
brain. In patients with dementia in long term care facilities, practicing yoga three times a week
for 12 weeks has reduced depression states and problem behaviors while increasing overall
mental health. With increased availability of alternative medicine practices, treatments such as
yoga have made an appearance with a nice balance of physical exercise and mental relaxation.
There is a shortage of evidence-based research on the effects of alternative exercise practices on
neurological conditions, but a study was completed with a Sit ‘N Fit chair yoga class to test for
different brain growth factors with AD. After 8 weeks of the chair yoga program, the researchers
noticed an improvement in the Six-Minute Walk Test, Gait Speed Test, and Berg Balance Scale
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Score. There were also increased levels of nerve growth factor (NGF) which protects basal
forebrain neurons that are otherwise affected in people with AD. After just 20 minutes of yoga
chanting, the NGF levels were significantly elevated, demonstrating the relationship between
yoga and increasing brain function (Mooventhan & Nivethitha, 2017).
There is a current study still recruiting participants that tests the combined treatment of
yoga practice and taking 800mg curcumin twice a day. However, the participants cannot begin
with any type of dementia and must have an MMSE > 24. The thought behind this was that
curcumin is isolated from turmeric and has been discovered to “inhibit several potential disease
pathways” (“Curcumin and Yoga Therapy for Those at Risk for Alzheimer’s Disease,” n.d.).
Paired up with yoga, which could initiate brain plasticity and growth, together they could
potentially prevent Alzheimer’s and other dementias before they begin.
There are still many factors to exercise in addition to the physical activity that could be
beneficial to patients with AD or other dementias. Exercising outdoors or having increased
exposure to sunlight can increase vitamin D production which can then increase bone density,
inevitably protecting AD patients if or when they fall. Physical activity can increase cognitive
reserve to prevent delirium in patients with dementia or AD. Many forms of exercise also have a
social component that can influence the human brain and cognition which could slow the
progression of AD. A lack of social interaction and involvement is something that appears to
relate with an increased risk of dementia for many older people who live alone, but very little
research has been completed on the direct relationship between social networks and AD. In
nursing homes, one intervention promoting social involvement demonstrated more successful
management of “transient agitation behavior” in people who had dementia compared to those
who didn’t have social intervention (Nelson & Tabet, 2015).
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Physical exercise for patients with AD
It has been supported by many studies that exercise does slow the decline in cognitive
ability for patients with AD. The specifics of how physical exercise works on a molecular level
to protect the brain is still undergoing research, but exercise is considered a recommended
“preventive and therapeutic non-pharmacological strategy” in helping people with
neurodegenerative diseases (Bernardo et al., 2016). Bernardo et al. also contrasts the adaptations
of brain matter after physical exercise to the contractile effects on skeletal muscles, saying that
the brain is associated with more of the systemic changes due to physical exercise. In mouse
models, a decrease in amyloid plaques and tau proteins were observed following exercise
training. This signifies that physical activity could help regulate the basic mechanisms that lead
to AD. The health of brain mitochondria appears to be tied to increased BDNF levels,
specifically with regards to improved glucose transport, increasing responsiveness of certain
enzymes, and preventing apoptosis of neural tissue. This directly impacts neurodegeneration and
highlights that an “acute bout of aerobic exercise seems to be sufﬁcient to increase BDNF
plasma levels in patients with AD” (Bernardo et al., 2016).
Müller et al., (2018) conducted a study that focused on a rare form of AD called
autosomal dominant Alzheimer’s disease (ADAD) which was shown to be strongly affected by
physical activity. ADAD affects β-amyloid processing and leads to a buildup of β-amyloid
plaques. The World Health Organization (WHO) and American College of Sports Medicine’s
guidelines were tested regarding 150 minutes of physical activity each week having “beneficial
effects on global cognition, cognitive decline, functional status, and AD biomarkers in the brain
and cerebrospinal fluid (CSF)” (Müller et al., 2018). The Clinical Dementia Rating (CDR) and
MMSE were the scales used to test memory function in this case. The CDR tests six areas
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including memory, orientation, judgement and problem-solving, community affairs, home and
hobbies, and personal care. This final score, called the Sum of Boxes (SOB) score ranges from 0
to 3, with 3 signifying severe dementia and 0 marking no dementia. Over 12 months, participants
reported their leisure-time activity (including swimming, walking, jogging, cycling, or tennis)
with 156 staying at or above the 150-minute recommendation per week and 68 participants
getting less than the guidelines suggested. In people with the mutation for ADAD, the MMSE
scores were higher in those who completed more regular physical activity. However, in this
study, among those who do not have the mutation, the MMSE score was not significantly
different between those who were more physically active. The CDR-SOB results for people with
the mutation also showed that a lower score (minor impairment) is associated with higher levels
of physical activity compared to a stronger impairment associated with less activity (Müller et
al., 2018).
Animal studies
Animal studies have been done with rats and mice to test the hypothesis of exercise
slowing the progression of AD. However, it has been questioned: are animal studies actually
valid or a distraction? Popular mouse models are testing familial AD because that is what can be
controlled and triggered by altering the genetic code (LaFerla & Green, 2012). Most of the
human population with AD however, has sporadic AD meaning that it started with age and a
trigger, not necessarily because of a directly inherited gene sequence. For the rest of the AD
population suffering from familial AD, it is similar to the mouse model.
In a mouse model study, Soto et al., (2015) concluded that aerobic exercise from midlife
to old age had a part in preventing neurovascular decline from old age along with increasing
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synaptic plasticity. In the absence of the APOE gene, however, this relationship did not exist
between exercise and neurovascular decline. This demonstrates the association between APOE
and neurodegeneration. Physical exercise in humans increases the cerebral blood flow,
neurogenesis, hippocampal volume, and angiogenesis, and improves memory (Soto et al., 2015).
Enhancing neurogenesis in rats with AD was the goal for one experiment completed by
Kim et al., (2014). This study consisted of four groups: a control group without exercise, a
control group with exercise, an Aβ25-35 injection only group, and Aβ25-35 injection and exercise
group. The Aβ25-35 injection is what was used to simulate the effects of AD on the brain. To test
their initial memory, the rats were placed in a light chamber for 60 seconds before a guillotine
door opened to reveal a dark chamber. The time was recorded to see how long before the rats
entered the dark chamber, and this was called “latency”. Immediately after entry, a guillotine
door closed behind the mouse and an electric shock of 75V was delivered to the floor grids for
three seconds. Five seconds after the shock ended, they were moved back to their home cages.
Twenty-four hours later, the latency to move into the dark chamber was measured again up to a
maximum of 600 seconds. This time there was no shock in the dark chamber. It appeared the rats
with the injection had a shorter latency period, which relates to a short-term memory impairment.
This would signify that the Aβ25-35 injection does represent some deficits in short term memory,
similar to AD (Kim et al., 2014).
The rats were anesthetized immediately after the latency testing, and their brains were
analyzed for BDNF expression, apical dendritic length, and neurogenesis in the hippocampus,
among other analyses. The researchers showed that the cells that were actively participating in
neurogenesis were decreased upon Aβ25-35 injection, but increased again with treadmill exercise
in both the injection group and the control group (Kim et al., 2014). This provides us with
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evidence that exercise does increase neurogenesis, both with AD and without the disease. In
either case, exercise increases neuronal growth even after being delayed or halted by a
neurodegenerative disease.
Treatments
Some medications are available along with some therapy programs to treat AD.
However, there is no reliable treatment available to cure Alzheimer’s, just to slow the
progression. These also don’t work in everyone. Many researchers now believe to find an
effective treatment to AD, it’s important that treatment begins in the early pre-symptomatic
stages of the disease (Ryman et al., 2014). This becomes difficult because the primary way to
diagnose AD is by the observation of symptoms in the affected individual. There are physical
and cognitive therapy programs including a new trial called EXERT. Beginning in June 2016
and hoping to collect results in June 2020, this trial is currently in progress. Enrolled are people
between the ages of 65 and 89 years old with inclusion criteria consisting of an MMSE score of
24+ for more than a high school education, and MMSE 22+ for people with at least some
college. More criteria include a CDR of 0.5, a caregiver or partner with at least weekly contact,
sedentary or underactive individuals, willing and able to travel to the YMCA 4 days/week for 18
months, and a modified Hachinski score of 4 or lower. The participants are randomly assigned to
the aerobic exercise group or the stretching-balance-range of motion group. The aerobic group
exercises at 70-80% of maximum heart rate for 30 min, with 10 minutes added for warm up and
an extra 5 minutes for cool down 4 times a week for 12 months. The stretching and balance
group will do the same time segments, but at 35% max heart rate or below (“Exercise in Adults
with Mild Memory Problems (EXERT),” n.d.). It will be interesting to see what the results will
show once this study is complete.

16

The current first line pharmacological treatment of Alzheimer’s includes
acetylcholinesterase inhibitors. By inhibiting acetylcholinesterase, we increase the amount of
acetylcholine that is available for use in the body. It doesn’t function by treating the disease
itself, but merely attempts to treat symptoms such as functional ability, behavior, and cognition
(Knowles, 2006). This helps the patients feel more comfortable with functioning in their
everyday life. The most common treatment option is the acetylcholinesterase inhibitor Aricept
(donepezil) which is effective for mild to moderate AD. Other medications that fall into this
same category for mild to moderate symptoms include Razadyne (galantamine) and Exelon
(rivastigmine). As AD progresses to become more severe, preferred medications work on
regulation of glutamate. When too much glutamate is present, brain cell death proceeds.
Namenda (memantine) is an N-methyl D-aspartate (NMDA) antagonist that can be used in
combination with Aricept in a combined form known as Namzaric (“How Is Alzheimer’s
Disease Treated?,” n.d.).
Like many diseases, people prefer to pair up a pharmacological treatment with a lifestyle
modification. As observed by many research studies that have been completed or are currently in
progress, physical activity may aid in slowing the progression of AD or as a primary preventative
treatment.
Future
The future of AD treatment is still foggy as we do not clearly understand the causes of
the disease. Using cholinesterase inhibitors and targeting NMDA antagonists are the two main
methods that we have available for pharmacological treatment of AD. Other main characteristics
for Alzheimer’s are neurodegeneration causing a decrease in hippocampal volume, decrease in
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BDNF, and creation of neurofibrillary tangles and -amyloid plaques. One of the ways that we
know to increase neurogenesis, hippocampal volume, and BDNF levels are with physical
exercise.
There are many studies currently in progress testing the relationship between exercise and
AD. A table outlining some of these tests can be found in Appendix A. The study titled “Effects
of Aerobic Exercise for Treating Alzheimer’s Disease (FIT-AD)” by Fang Yu, PhD, measures
cognition and hippocampal volume every 3 months. The intervention is 20-50 minutes of cycling
or range-of-motion exercises, 3 times a week, for a year (“Effects of Aerobic Exercise for
Treating Alzheimer’s Disease” n.d.). Another study, on the other hand, led by Jeff Burns, MD, of
University of Kansas Medical Center, examines how quantity of exercise may affect AD. Here,
there are three exercise groups, each with increasing amounts of exercise for the week. One
group exercises 75 minutes over 3 days, the second group exercises 150 minutes over 3-5 days,
and the last group exercises 225 minutes over 4-5 days (“Dose Response Study of Aerobic
Exercise in Older Adults" n.d.). One more ongoing test compares different exercise intensities
with groups performing activities at 70% max heart rate (HR) compared to alternating 60% max
HR and 80% HR (“Alzheimer’s Disease and Physiological, Cognitive Function and BDNF
Levels of Plasma Adaptation After Exercise Training” n.d.). Once all these results are organized,
it will be interesting to compare their outcomes to determine a beneficial activity regimen.
Unfortunately, I could not run my own research study because of the population I wanted
to work with, but I have plans for how I would run a study relating exercise to the progression of
Alzheimer’s.
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Proposed Study
Subjects: Previously sedentary people will be recruited who all have been diagnosed
with Alzheimer’s for at least a month and are over 60 years old. Levels of decline will be
determined with CDR and should be between 0.5 and 2. All subjects will be in an assisted living
facility to control for environmental factors that might affect the results.
Methods: A PET scan and MMSE score will be completed and recorded before the
study begins to determine amyloid plaque buildup and to collect baseline hippocampal volume.
Subjects will be randomly assigned to one of three groups aerobic exercise, yoga, or control
group. The aerobic group will complete cycling exercise, at 60% of maximum heart rate for 3,
10-minute periods with 5-minute rest between each workout, giving a 2:1 work to rest ratio.
This exercise program will be conducted 3 days per week. The yoga group will meet 3 days per
week and complete 10 minutes of yoga poses followed by 5 minutes of rest for a total of 30
minutes of yoga poses. The control group will meet 3 days per week for 40 minutes at which
time they will watch a predetermined video. The groups will proceed with this plan for 16 weeks.
PET scans and MMSEs will be completed before and after the study to look for changes in
hippocampal volume and amyloid plaques. Statistical analysis will be conducted using a twoway analysis of variance (group by test) with a priori level of significance set at p<0.05. Posthoc analysis will be done using Tukey Honest Significant Difference Test.
Conclusion
Past research has seemed to indicate that there is promise in the use of exercise as a
means to treat AD. Aerobic exercise seems to have a greater influence than strength and
flexibility exercises, however, any physical activity is better than adopting a sedentary lifestyle.
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If a patient is past the point where they can exercise aerobically, it would still be valuable to get
them up and participating in flexibility training, yoga, or strength exercises. Group exercise also
includes socialization that can also play a role in how AD progresses in individuals. Because the
brain has the characteristic of plasticity and it has been shown that exercise can increase plastic
changes in the brain, it makes sense that physical activity should be something that people do
throughout their lives to improve, maintain, and slow degeneration of cognitive function.
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Appendix A
Current ClinicalTrials.gov Studies
Research
Study/Location

Subjects

Exercise mode

Variables

Results

Effects of Aerobic
Exercise for Treating
Alzheimer’s Disease
(FIT-AD): (Fang Yu,
PhD) University of
Minnesota -Clinical and
Translational Science
Institute

66yo+ with probable or
possible AD.

Cycling

Independent: 20-50 min
3X/wk of cycling or
range of motion
exercises.

Results not posted yet.

15 ≤ MMSE score ≤ 26.
CDR Score 0.5-2

Dependent: Cognition
measured after 3, 6, 9,
and 12 months with the
Alzheimer’s Disease
Assessment ScaleCognitive Subscale.
Hippocampal volume
measured with an MRI.

Community dwelling
Stable on AD drugs >1
month

Benefits of Exercise in
Alzheimer’s Disease:
(Carmela Tartaglia, MD)
University Health
Network, Toronto

60-95yo with probable
AD.

Personalized
outpatient
exercise program

CDR < 2
10-25 on Montreal
Cognitive Assessment
Presence of respective
caregiver

Effect of Physical
Exercise on Alzheimer
Patients: (Steen G
Hasselbalch)
Copenhagen University
Hospital, Rigshospitalet

50-90yo
MMSE score 20+. Mild to
moderate AD.
Imaging consistent with
AD
Home-dwelling with
caregiver available
At least 7 years of
schooling
Stable on anti-dementia or
mood stabilizing drugs for
≥ 3 months

Independent: A
personalized exercise
regimen is made for each
participant in the exercise
group. The other group
did not deviate from
normal activity levels.

Results not posted yet.

Dependent: Behavioral
Symptoms measured on
the Montreal Cognitive
Assessment and volume
loss via MRI
Patient choice of
stationary bike,
treadmill, or
cross-trainer

Intervention: Supervised
1 hr 3X/wk moderate
aerobic exercise for 16
weeks. Control group:
receiving usual care.
Dependent: Complete
blood sampling to
measure biomarkers. A
subgroup will also get an
MRI, PiB-PET and
lumbar puncture to check
for changes in structure
and β-amyloid
accumulation.

Results not posted yet.

25
Physical Exercise as an
Additional Treatment
for Alzheimer Disease:
(Jerson Laks)
Universidade Federal do
Rio de Janeiro, Brazil

AD diagnosis
MMSE score ≥ 15

30 min 2X/week
on treadmill at
moderate
intensity

CDR score 1
Regular use of
anticholinesterase drugs ≥
6 months

65yo+
Sedentary individuals

0, 75, 150 or 225
minutes of
exercise/week

Control: maintain current
physical activity
Exercise 1: (50% group)
75 minutes spread over 3
days.

Community dwelling with
caregiver
CDR score 0. No dementia

Exercise 2: (100% group)
150 minutes spread over
3-5 days.

Stable medications ≥ 30
days

Exercise 3: (150% group)
225 minutes spread over
4-5 days.
After 26 weeks, they
tested visuospatial
processing, VO2max,
and a 9-item physical
performance test.

Alzheimer's Disease and
Physiological, Cognitive
Function and BDNF
Levels of Plasma
Adaptation After
Exercise Training
(MARAE): (Jean-Luc
Ms Fanon, Doctor)
University Hospital
Center of Martinique

60yo+
Alzheimer’s Disease
patients
Score of 15+ on MMSE
Not regularly biking
Ability to pedal

Results not posted yet.

Dependent: Measured
cognitive function with
CAMCOG, Trail Making
Test A, Digit Span,
Stroop Test, Rey
auditory-verbal learning
test and Clock test.
Physical evaluation will
be with the BERG
balance scale, Sit-tostand, functional reach
test, and the “time to up
and go” test.

6+ months without
physical exercise

Dose Response Study of
Aerobic Exercise in
Older Adults: (Jeff
Burns, MD) University of
Kansas Medical Center

Independent: The
exercise group will
treadmill at 60%
VO2max for 30 min
2X/wk.

Endurance
training at 70%
of maximal heart
rate 2X/week
Interval training
with 4 min at
60% and 4 min
at 80% of
maximal heart
rate.
Control:
therapeutic

Independent: 20
participants will cycle at
70% max heart rate (HR)
2X/wk. 20 will do
interval training with 4minute base (60%HR)
and 1 minute peak
(80%HR) 2X/wk.
Control group had 9
therapeutic meetings.
Dependent: The
experimental group’s
maximum aerobic power,

Some of these outcomes
displayed strong
relationships while others
did not.
Visuospatial Processing
improved with any level
of exercise, Maximal
Oxygen Consumption and
Simple Attention both
improved directly with
more exercise. Physical
Performance Tests and Set
Maintenance & Shifting
showed no correlation
with exercise. Verbal
memory tended to
decrease with more
exercise. The Reasoning
outcome showed no
exercise is best.
Results not posted yet.

26

Tai Chi 6-Form Sports
Apparatus With
Alzheimer's Disease:
(Alice May-Kuen Wong)
Chang Gung Memorial
Hospital

59-92yo
Mild and moderate AD
patients

education
meetings

endurance, heart rate,
prehension strength,
MMSE, REY’s test, and
BDNF plasma levels
were examined one
month into the study and
one month after
intervention ended.

12 week Tai chi
6 form with
music rhythm

Year 1: 12 weeks of Tai
Chi 6-form along with
music rhythm.

12 week
computer based
cognitive
training games

Year 2: 12 weeks of
computer-based cognitive
training games.

12 week
Physico-Mental
rehabilitation
Wii.

Year 3: 12 weeks of
Physico-Mental
rehabilitation Wii.
Measure balance
outcomes.

Results not posted yet.

